MAT Resources

Use of remdesivir for the treatment of COVID-19

Remdesivir, under the trade name VEKLURY, should be used according to the prescribing guidelines provided in the FDA approval issued 10/2020.1 The drug is intended for use in patients 12 years of age and older and weighing at least 40 kg for the treatment of...

COVID-19 Frequently Asked Questions

This document outlines a series of responses to COVID-19 frequently asked questions, including information about finding New Mexico COVID-19 cases by county, risk of transmission in certain settings (e.g. dining, gyms), and COVID-19 deaths. Download this resource

Use of ivermectin in the treatment of COVID-19

The NM Medical Advisory Team does not recommend ivermectin therapy in patients with COVID-19 infection outside of clinical trials until more data is available. Current evidence for using ivermectin in the treatment of COVID-19 is still largely speculative. There is...

Mask Guidelines for Children and Youth (Revised)

In response to the COVID-19 pandemic, masks will be required of everyone in NM except infants and children under the age of 3 in public places, with exceptions for eating and drinking, and medical requirements.• The U.S. Centers for Disease Control (CDC) does not...